BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23037713)

  • 1. The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma.
    Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Ang YS; Sharrocks AD
    Br J Cancer; 2012 Nov; 107(10):1766-75. PubMed ID: 23037713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.
    Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Sharrocks AD; Ang YS
    BMC Res Notes; 2015 Nov; 8():676. PubMed ID: 26576650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects.
    Poyil PK; Siraj AK; Padmaja D; Parvathareddy SK; Thangavel S; Alobaisi K; Diaz R; Begum R; Haqawi W; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Mol Oncol; 2024 Mar; 18(3):691-706. PubMed ID: 38361222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.
    Fu Z; Malureanu L; Huang J; Wang W; Li H; van Deursen JM; Tindall DJ; Chen J
    Nat Cell Biol; 2008 Sep; 10(9):1076-82. PubMed ID: 19160488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.
    Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S
    J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb.
    Down CF; Millour J; Lam EW; Watson RJ
    Biochim Biophys Acta; 2012 Aug; 1819(8):855-62. PubMed ID: 22513242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
    Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of the FOXM1 target gene network and its coregulatory partners in oesophageal adenocarcinoma.
    Wiseman EF; Chen X; Han N; Webber A; Ji Z; Sharrocks AD; Ang YS
    Mol Cancer; 2015 Mar; 14():69. PubMed ID: 25889361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival.
    Wang R; Song Y; Xu X; Wu Q; Liu C
    Clin Transl Oncol; 2013 Aug; 15(8):626-32. PubMed ID: 23359173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects and molecular mechanisms of inhibiting FOXM1 expression on ovarian cancer cell line SKOV3 by Lentiviral vector].
    Chen GQ; Yao ZW; Qi HB; Zhang H; Luo Y; Qin XF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):29-32. PubMed ID: 22230500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrative "Omics" Approach, for Identification of Bona Fides PLK1 Associated Biomarker in Esophageal Adenocarcinoma.
    Bibi N; Rashid S; Nicholson J; Malloy M; O'Neill R; Blake D; Hupp T
    Curr Cancer Drug Targets; 2019; 19(9):742-755. PubMed ID: 30747067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
    Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I
    Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions of polo-like kinase 1 in human cancers.
    Weng Ng WT; Shin JS; Roberts TL; Wang B; Lee CS
    J Clin Pathol; 2016 Jul; 69(7):557-62. PubMed ID: 26941182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
    Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
    Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
    Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
    Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension.
    Wilson JL; Wang L; Zhang Z; Hill NS; Polgar P
    PLoS One; 2019; 14(8):e0221728. PubMed ID: 31437238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells.
    Xu N; Zhang X; Wang X; Ge HY; Wang XY; Garfield D; Yang P; Song YL; Bai CX
    Acta Pharmacol Sin; 2012 May; 33(5):675-81. PubMed ID: 22447226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.
    Shirakawa J; Fernandez M; Takatani T; El Ouaamari A; Jungtrakoon P; Okawa ER; Zhang W; Yi P; Doria A; Kulkarni RN
    Cell Metab; 2017 Apr; 25(4):868-882.e5. PubMed ID: 28286049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.